An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
Optimizing the Use of Bispecific Antibodies in Hematologic Malignancies 1.00 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Managing Earlier Integration of Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia 0.75 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Review of Oral Targeted Therapies in Acute Myeloid Leukemia 0.75 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Myelodysplastic Syndromes: Treatment Updates and Emerging Data 0.50 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Management of Multiple Myeloma: Smoldering, Newly Diagnosed, and Relapsed/Refractory Disease 2.25 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Managing Post-Treatment Complications for Multiple Myeloma and Acute Lymphocytic Leukemia 1.00 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Debate: Is the Addition of Polatuzumab Vedotin the New Standard First-Line Therapy for Diffuse Large B-Cell Lymphoma? 0.75 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Diffuse Large B-Cell Lymphoma: Sequencing Therapy for Relapsed/Refractory Disease 0.50 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Updates in Prognosis and Treatment 1.00 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
What is Optimal First-Line Management of Advanced Classic Hodgkin Lymphoma? 0.75 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
NCCN Guidelines® Insights - Survivorship, Version 2.2024 1.00 12/10/2024 - 12:00am to 12/10/2025 - 12:00am
Unraveling Cancer Pain Dynamics 1.00 12/16/2024 - 12:00am to 10/31/2025 - 11:59pm
Patient Management Simulator: Treatment Recommendations for Kidney Cancer with Management of Immunotherapy-Related Toxicities 12/19/2024 - 12:00am to 12/19/2025 - 12:00am
An Interactive Case-Based Review of Chronic Lymphocytic Leukemia: Experts Explore the Latest Evidence and Guideline Updates 2.00 12/20/2024 - 12:00am to 12/20/2025 - 12:00am
Vital Questions for Treatment of Bladder Cancer: Expert Insights on Recent and Near-Future Changes 1.00 12/20/2024 - 12:00am to 12/20/2025 - 12:00am

Pages